Donors


DNDi is pleased to thank the various donors who are committed to the mission and vision of DNDi; and without whom, DNDi would not have been able to achieve its initial successes.
THANKS TO OUR DONORS
DNDi would like to thank the following donors for their support of DNDi’s activities since July 2003:
PUBLIC INSTITUTIONAL DONORS
Department for International Development (DFID) / UNITED KINGDOM• Grant period: 2006-2013
• Support to DNDi initiative
• Total amount: GBP 24.5 million
•
www.dfid.gov.uk• Link to
press release
Dutch Ministry of Foreign Affairs (DGIS) / THE NETHERLANDS • Grant period: 2006-2009
• Support to DNDi malaria project (FACT)
• Total amount: EUR 2’975’000
•
www.minbuza.nl/en/ministry European Union - Framework Programme 5 and 6• Grant period: 2002-2006 / 2006-2009
• Support to DNDi malaria project (FACT) and Human African Trypanosomiasis Platform
• Total amount: EUR 1'631'587
•
cordis.europa.eu/inco/home_en.html ec.europa.eu/research/iscp/index.cfm French Development Agency (AFD) / FRANCE • Grant period: 2006-2010
• Support to DNDi malaria project (FACT)
• Total amount : EUR 2’000’000
•
www.afd.fr• Link to initial
press release
GTZ on behalf of the Government of the Federal Republic of Germany / GERMANY• Grant period: 2008 –-2009
• Support to specific discovery, preclinical/clinical projects (Chagas lead optimisation, Fexinidazole)
• Total amount: EUR 1’000’000
•
www.gtz.de/en/Ministry of Foreign and European Affairs (MAEE) / FRANCE • Grant period: 2007-2009
• Support to specific projects for Human African Trypanosomiasis (Fexinidazole, NECT) and visceral leishmaniasis (Buparvaquone, Paromomycin, AmBisome) and capacity building (LEAP, HAT platform)
• Total amount: EUR 5’955’000
•
www.diplomatie.gouv.fr/fr/Ministry of Foreign and European Affairs (MAEE) / FRANCE • Grant period: 2009-2010
• Support to specific discovery and preclinical projects (IPK screening, HAT lead optimisation, Oxaborole for HAT)
• Total amount: EUR 1’300’000
•
www.diplomatie.gouv.fr/fr/National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) / UNITED STATES OF AMERICA• Grant period: 2007-2010
• Support to Amphotericin B Polymer project
• Total amount USD 2'386'733
•
www.nih.gov/ http://www3.niaid.nih.gov/• Link to
press release
Region of Tuscany / ITALY• Grant period: 2006-2007
• Support to Paromomycin project
• Total amount: EUR 200’000
•
www.regione.toscana.it/prehome_1024.htm Republic and Canton of Geneva, Institution Department, International Solidarity / SWITZERLAND • Grant period: 2004-2009
• Support to Paromomycin project
• Total amount: CHF 1’000’000
•
www.ge.ch Spanish Agency for International Development Cooperation (AECID) / SPAIN• Grant period: 2007-2010
• Support to DNDi initiative
• Total amount: EUR 10’000’000
•
www.aecid.es/web/es/aecid/• Link to
press release
Swiss Agency for Development and Cooperation (SDC) / SWITZERLAND• Grant period: 2005-2006
• Support to DNDi malaria project (FACT)
• Total amount: CHF 120’000
•
www.deza.ch/en/Home PRIVATE DONORSBill & Melinda Gates Foundation / UNITED STATES OF AMERICA • Grant period: 2007-2012
• Total amount: USD 27’229’285
• Support to HAT lead optimization and VL lead optimisation project
•
www.gatesfoundation.org/default.htm • Link to
press releaseBill & Melinda Gates Foundation / UNITED STATES OF AMERICA • Grant period: 2009-2014
• Total amount: USD 15’000’000
• Support to the clinical development of fexinidazole for the treatment of HAT
•
www.gatesfoundation.org/default.htm • Link to
press release
Médecins Sans Frontières (Doctors without Borders) / INTERNATIONAL• Grant period:2003-2014
• Total amount: EUR 43’000’000
• Support to DNDi initiative
•
www.msf.org• Link to
press releasePRIVATE FOUNDATIONS AND PRIVATE INDIVIDUAL DONORS
Fondation André & Cyprien / SWITZERLAND
Medicor Foundation / LIECHTENSTEIN
The Sasakawa Peace Foundation / JAPAN
The Starr International Foundation / SWITZERLAND and others that would like to remain anonymous.